Our Research

Discover our recent findings, catch up with news, and review in-depth resources and case studies.

Ultra-Trace NMBA Detection Using HILIC-MS | Resolian

Ultra-Trace NMBA Detection Using HILIC-MS

Learn how Resolian achieved 0.8 ng/mL NMBA detection using HILIC-MS – overcoming reverse-phase limitations for ultra-trace nitrosamine analysis in drug products.
Read more
Platform SFC-UV Method for GMP Analysis of Vitamin E in a Range of Vitamin E Supplement Matrices

Sustainable SFC-UV Method for Vitamin E Analysis

Discover how Resolian’s platform SFC-UV method analyzes vitamin E across multiple formulations – reducing organic solvent use while meeting GMP requirements.
Read more
Analytical Sciences Poster Videos Thumbnail - DoE Optimisation

LC-MS Sensitivity Optimization Using DoE

Discover how Resolian increased LC-MS sensitivity by 438% using Design of Experiments – achieving required detection limits without new equipment investment.
Read more

Preventing False Positives in Nitrosamine Testing

False positives in nitrosamine testing can trigger unnecessary product recalls, regulatory scrutiny, and supply chain disruptions—threatening patient access to critical therapies. But what if the contamination isn’t from your product at all?
Read more

Resolian Fordham UK Analytical Sciences Lab Tour

Take a virtual tour of Resolian’s Fordham analytical sciences laboratories. Located in Cambridgeshire, England, Resolian’s purpose-built analytical laboratories deliver comprehensive analytical solutions to support pharmaceutical and biopharmaceutical development worldwide.
Read more
Optimizing Peptide Permeability Assays: Insights from Our GRC 2025 Poster Presentation

Optimizing Peptide Permeability Assays

Our work, presented at GRC 2025, focuses on overcoming the analytical and biological hurdles associated with peptide permeability testing. The MDCK-MDR1 cell model is a well-established system for evaluating P-glycoprotein (P-gp)-mediated transport, commonly used for small molecules. But peptides, due to their high molecular weight, lipophilicity, and strong intracellular binding, require a more nuanced approach.
Read more
Scroll to Top

Resolian Brisbane Australia Bioanalytical Lab Tour

Take a virtual tour of Resolian’s Brisbane bioanalytical laboratory.

Located in the center of Brisbane, Australia, Resolian Bioanalytics is a purpose-built bioanalytical laboratory that can provide comprehensive service to support pre-clinical and clinical studies in Australia and worldwide.

Take advantage of the world’s fastest-growing clinical trials region to accelerate your global clinical development.

Our state-of-the-art bioanalytical facility in Brisbane, Australia, supports pre-clinical and clinical testing. 

Your Trusted Professionals In:

  • LC-MS
  • Immunoassay
  • Biomarkers
  • PBMC Isolations
  • Flow Cytometry
Learn more about our Brisbane Lab

Zhiyang Zhao, Ph.D.

Chief Scientific Officer

Linkedin

Zhiyang Zhao, Ph.D., serves as Chief Scientific Officer (CSO) at Resolian. Dr. Zhao has over 30 years of pharmaceutical industry experience with special focus on drug metabolism and bioanalysis of small and large molecules in drug discovery and development. Dr. Zhao has previously held positions at Pfizer, GlaxoSmithKline, and Amgen. Before joining Resolian in 2015, Dr. Zhao served as Site Director of Preclinical Research at Amgen in Cambridge, Massachusetts, for over a decade. 

Currently, Dr. Zhao serves as an Adjunct Professor at the Eshelman School of Pharmacy of the University of North Carolina at Chapel Hill, North Carolina, and as Editor-in-Chief of Drug Metabolism & Bioanalysis Letters, a journal by Bentham Science, which publishes in all areas of drug metabolism and bioanalysis. Dr. Zhao received his Ph.D. degree in Medicinal Chemistry from Virginia Polytechnic and State University (popularly known as Virginia Tech) in Blacksburg, Virginia. 

 

Patrick Bennett

Chief Executive Officer

Linkedin

Patrick Bennett has over 35 years of experience in pharmaceutical analysis and laboratory management. Now Chief Business Officer at Resolian, Patrick’s experience includes the roles of Strategic Marketing Director for Pharma with Thermo Fisher Scientific, LabCorp, and Vice President of Strategy and Development with PPD. 

Patrick earned a B.S. degree in Toxicology and a M.S. degree in Pharmacology from the College of Pharmacy and Allied Health at St. John’s University and an M.B.A in International Marketing from the Martin J. Whitman School of Management at Syracuse University.